The effectiveness of vitamin D on diabetic neuropathy

Comparing the effectiveness of 50000 units of vitamin D orally/weekly for 12 weeks and control group on diabetic neuropathy- before and after study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017102325266N2

Enrollment

Registered

2017-11-08

Start date

2017-11-06

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic neuropathy. Non-insulin-dependent diabetes mellitus

Interventions

Subjects receive 50,000 units of vitamin D per week per week for 12 weeks during the intervention period..

Eligibility

Sex/Gender

All

Age

40 Years to 65 Years

Inclusion criteria

Inclusion criteria: Type 2 diabetes, having a medical record at the Yazd diabetes research center, willingness to participate in the study, diagnosis of diabetic neuropathy through physical examination and obtaining a score of more than 4 from the Michigan Neuropathy Screening Questionnaire Instrument (MNSI) aged 40-60 years old,

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The severity of diabetic neuropathy. Timepoint: Before the intervention, After the intervention. Method of measurement: Michigan Neuropathy Screening Instrument (MNSI).;Vitamin D. Timepoint: Before the intervention, After the intervention. Method of measurement: Blood Test.	—

Secondary

Measure	Time frame
HbA1C. Timepoint: Before the intervention, After the intervention. Method of measurement: Blood Test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarzieh Abutorabi

Yazd University of Medical Science

marzie.ab@gmail.com+98 35 3728 0226

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026